Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia pos
| Image |  |
|---|---|
| Description | scientific article published on 3 July 2008 |
| Author/s |
author: François Guilhot Maya Koren-Michowitz |
| Publication date | July 3, 2008 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |